The Lyme Test Access Program (Lyme-TAP) is a nationwide patient assistance program to provide assistance for initial Lyme-related lab tests to patients who demonstrate true financial need.
If approved, you may be reimbursed for up to 75% of your out-of-pocket costs of testing from a qualified CLIA/Medicare approved laboratory of your choice. Funds are limited & are available on a first-come, first-served basis. Children under 18 years of age are given priority. The intention of this program is to help as many patients in need as possible. It is not intended to cover insurance deductibles or to cover patients not truly in financial need. Payments of approved grants may take several weeks.
This nationwide assistance program was made possible by a very generous donation from IGeneX Inc., a CLIA/Medicare licensed laboratory. Any CLIA/Medicare licensed laboratory may be selected for testing: you do not have to use IGeneX for this program.
If approved, you may be reimbursed for up to 75% of your out-of-pocket costs of testing from a qualified CLIA/Medicare approved laboratory of your choice. Funds are limited & are available on a first-come, first-served basis. Children under 18 years of age are given priority. The intention of this program is to help as many patients in need as possible. It is not intended to cover insurance deductibles or to cover patients not truly in financial need. Payments of approved grants may take several weeks.
This nationwide assistance program was made possible by a very generous donation from IGeneX Inc., a CLIA/Medicare licensed laboratory. Any CLIA/Medicare licensed laboratory may be selected for testing: you do not have to use IGeneX for this program.
